At Pure Medical Spa, we help patients understand how these therapies work so they can make informed decisions based on their bodys needs
The median CQ (control drug) and MB IC 50 were 28.14 70.8 (range from 7.97 to 243.2) and 2.41 5.36 (range from 0.01 to 18.52) nM, respectively

Research Dose Ranges Preclinical animal studies: 110 mcg/kg (nanogram to microgram range) once or twice daily Extrapolated human equivalent range commonly discussed in clinical literature: 200500 mcg/day Human pilot IV data: doses up to 20 mg were tolerated without adverse effects in two healthy adults (Lee & Burgess, 2025) though this is far above typical outpatient dosing Protocol: Musculoskeletal / Connective Tissue Healing For tendon, ligament, or muscle injury recovery, the standard approach in clinical functional medicine practice involves: SubQ injection at 200500 mcg once daily , injected near (not into) the injury site Cycle length: typically 48 weeks , with reassessment Often combined with TB-500 (thymosin beta-4) for synergistic tissue remodeling the BPC+TB stack Best results seen alongside physical therapy, not as a substitute for it Protocol: Gut and GI Mucosal Healing For IBD, gut permeability, NSAID damage, or H

[1] GHK-Cu acts as a potent attractant for various cells involved in the healing process, including capillary cells, mast cells and macrophages
Drivers 2.2.2
Intraperitoneal injection was most frequently applied (12, 1719), whereas one study relied on oral administration via drinking water (16)